The Joint Committee on Vaccination and Immunization released an independent report that included discussions on rolling out any safe and effective vaccine, once it is cleared for use in the UK.
The committee which advises UK health services on vaccination has considered who should be given priority for any vaccine.
Liverpool Echo reports that the advisory group was strongly in favor of a simple age-based program, which would likely result in faster delivery and better adoption among those most at risk.
This tentative list of priorities is subject to change but is based on vaccines in development and tentative vaccine availability timelines.
The AP reports that the JCVI added that any vaccination program must also ensure good coverage among Black, Asian and Ethnic Minority (BAME) communities, as well as those living in deprived areas.
Groups with underlying conditions that may lead to priority vaccination include people who have had a stroke, people with poorly controlled diabetes, chronic lung disease, obesity (BMI over 40), or breast disease. liver.
Jon Cohen, Professor Emeritus of Infectious Diseases at Brighton and Sussex Medical School, said: “The publication of an initial discussion on how a Covid vaccine would be deployed is a welcome and important first step. “
According to him, the “delicate question” will be whether the first available vaccine “offers only limited protection and – as is certainly possible – is only weakly effective in the elderly”.
“As JCVI says, this can dramatically change the prioritization,” he added.
He said future data would depend on the results of global vaccine trials.
According to the report, the provisional ranking of priorities for those at risk is as follows:
- nursing home resident of older adults and nursing home workers
- every 80 years and over and health and social service workers
- all these 75 and over
- all these 70 and over
- all those 65 and over
- high-risk adults under 65
- moderate-risk adults under 65
- all these 60 years and over
- all these 55 and over
- all these 50 years and over
rest of the population (priority to be determined)
This list could change considerably depending on whether the vaccine is less effective or not suitable for the elderly.
The race to develop a vaccine to end the global pandemic has meant that there are now more than 170 candidate vaccines now being tracked by the World Health Organization (WHO).
Vaccines generally take more than two years of testing before they are ready for use. However, earlier this week, Health Secretary Matt Hancock said a “massive deployment” of a vaccine could be seen early next year.
The UK currently has access to six different Covid-19 vaccine candidates under development.
Professor Robin Shattock, who is leading the Covid-19 vaccination effort at Imperial College London, told the European Parliament on Tuesday that a coronavirus could be approved for use by the middle of next year.
He said the trials are showing promising results and human volunteers appear to “respond well” to the vaccine.